Objective: Angiotensin II promotes growth and angiogenesis via type 1 receptors (AGTR1) in certain tumors. In this study, we examine the bone marrow AGTR1 expression in multiple myeloma (MM) and its relationship with the regulation of angiogenesis and prognostic factors.
Materials And Methods: Bone marrow mRNA levels of 39 MM patients and 15 healthy controls were analyzed with quantitative RT-PCR. Immunohistochemical staining of the tissue vascular endothelial growth factor (VEGF), CD34, and factor VIIIrAg (fVIIIrAg) was used to assess bone marrow angiogenesis.
Results: Bone marrow samples of the patients showed increased VEGF, fVIIIrAg, and CD34 staining and higher expression levels when compared to controls. Patients with severe-diffuse bone marrow infiltration showed higher bone marrow VEGF, fVIIIrAg, CD34, and mRNA levels when compared to other patients.
Conclusion: expression was found positively correlated with plasma β2-microglobulin level and patients with increased AGTR1 expression showed increased bone marrow CD34 levels.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682785 | PMC |
http://dx.doi.org/10.4274/tjh.galenos.2019.2018.0420 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!